Colonial Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Colonial Trust's ALNY Position: Q2 2026 in Review
Colonial Trust increased its Alnylam Pharmaceuticals (ALNY) stake by 2.9% in Q2 2026, buying an estimated $905 and bringing the position to 106 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #593.
Colonial Trust first reported a position in ALNY in Q4 2023 and has held it in 6 quarters since. The position peaked at $39.4K in Q4 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Colonial Trust held 106 shares of Alnylam Pharmaceuticals worth $31.8K as of Q2 2026.
- Colonial Trust bought 3 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $905.
- Alnylam Pharmaceuticals made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #593 holding.
- Colonial Trust first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
- Colonial Trust's Alnylam Pharmaceuticals position peaked at $39.4K in Q4 2025.
- 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.